Source plasma is collected from healthy, voluntary donors through a process called plasmapheresis and is used exclusively for further manufacturing into final therapies (fractionation) or other diagnostic uses. Donors may be compensated.
The native protein content is 5 to 5.3% and selection of source plasma may be based on clients' product specifications, application or other concerns.